DCCPS- Surveillance Research Program

DCCPS-监视研究计划

• 批准号: 10273211
• 负责人: LEONARD FREEDMAN
• 金额: $ 51.21万
• 依托单位: LEIDOS BIOMEDICAL RESEARCH, INC.
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-08-31 至 2021-08-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10273211
• 关键词: Cancer Surveillance Research Program; Collection; Data; Data Collection; Division of Cancer Control and Population Sciences; Ensure; Fostering; Modeling; Outcome; Pharmacy facility; Process; Residual state; SEER Program; Tissue Banks; Trust; improved; new technology

Abstract - As the SEER programs continue to expand (in quality, expanded outcomes collection, and utilization) it is critical to establish a model and a set of processes for ensuring confidence and trust in the use and application of the SEER data. This is particularly critical as SEER approaches potential opportunities to: 1) integrate new technologies to curate date (e.g., NLP), 2) improve quality and efficiency of existing platforms, 3) expand the scope of data collection (e.g., Residual Tissue Repository), and 4) foster new partnerships with other organizations (e.g., commercial pharmacy chains).

翻译后摘要-作为SEER计划继续扩大（在质量，扩大成果收集和利用），它是至关重要的建立一个模型和一套流程，以确保信心和信任的使用和应用的SEER数据。这一点尤其重要，因为SEER接近潜在的机会：1）整合新技术以管理数据（例如，NLP），2）提高现有平台的质量和效率，3）扩大数据收集的范围（例如，残留组织储存库），以及4）促进与其他组织的新伙伴关系（例如，商业连锁药店）。